These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

815 related items for PubMed ID: 16818648

  • 1. Antibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal models.
    Kirpotin DB, Drummond DC, Shao Y, Shalaby MR, Hong K, Nielsen UB, Marks JD, Benz CC, Park JW.
    Cancer Res; 2006 Jul 01; 66(13):6732-40. PubMed ID: 16818648
    [Abstract] [Full Text] [Related]

  • 2. Sterically stabilized anti-HER2 immunoliposomes: design and targeting to human breast cancer cells in vitro.
    Kirpotin D, Park JW, Hong K, Zalipsky S, Li WL, Carter P, Benz CC, Papahadjopoulos D.
    Biochemistry; 1997 Jan 07; 36(1):66-75. PubMed ID: 8993319
    [Abstract] [Full Text] [Related]

  • 3. Anti-HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery.
    Park JW, Hong K, Kirpotin DB, Colbern G, Shalaby R, Baselga J, Shao Y, Nielsen UB, Marks JD, Moore D, Papahadjopoulos D, Benz CC.
    Clin Cancer Res; 2002 Apr 07; 8(4):1172-81. PubMed ID: 11948130
    [Abstract] [Full Text] [Related]

  • 4. Tumor targeting using anti-her2 immunoliposomes.
    Park JW, Kirpotin DB, Hong K, Shalaby R, Shao Y, Nielsen UB, Marks JD, Papahadjopoulos D, Benz CC.
    J Control Release; 2001 Jul 06; 74(1-3):95-113. PubMed ID: 11489487
    [Abstract] [Full Text] [Related]

  • 5. Antibody targeting of doxorubicin-loaded liposomes suppresses the growth and metastatic spread of established human lung tumor xenografts in severe combined immunodeficient mice.
    Sugano M, Egilmez NK, Yokota SJ, Chen FA, Harding J, Huang SK, Bankert RB.
    Cancer Res; 2000 Dec 15; 60(24):6942-9. PubMed ID: 11156394
    [Abstract] [Full Text] [Related]

  • 6. Lymphoid tissue targeting of anti-HIV drugs using liposomes.
    Désormeaux A, Bergeron MG.
    Methods Enzymol; 2005 Dec 15; 391():330-51. PubMed ID: 15721390
    [Abstract] [Full Text] [Related]

  • 7. Targeted delivery of anti-CD19 liposomal doxorubicin in B-cell lymphoma: a comparison of whole monoclonal antibody, Fab' fragments and single chain Fv.
    Cheng WW, Allen TM.
    J Control Release; 2008 Feb 18; 126(1):50-8. PubMed ID: 18068849
    [Abstract] [Full Text] [Related]

  • 8. Epidermal growth factor receptor-targeted immunoliposomes significantly enhance the efficacy of multiple anticancer drugs in vivo.
    Mamot C, Drummond DC, Noble CO, Kallab V, Guo Z, Hong K, Kirpotin DB, Park JW.
    Cancer Res; 2005 Dec 15; 65(24):11631-8. PubMed ID: 16357174
    [Abstract] [Full Text] [Related]

  • 9. Enhanced pharmacodynamic and antitumor properties of a histone deacetylase inhibitor encapsulated in liposomes or ErbB2-targeted immunoliposomes.
    Drummond DC, Marx C, Guo Z, Scott G, Noble C, Wang D, Pallavicini M, Kirpotin DB, Benz CC.
    Clin Cancer Res; 2005 May 01; 11(9):3392-401. PubMed ID: 15867240
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Anti-HER2 immunoliposomes for co-delivery of paclitaxel and rapamycin for breast cancer therapy.
    Eloy JO, Petrilli R, Chesca DL, Saggioro FP, Lee RJ, Marchetti JM.
    Eur J Pharm Biopharm; 2017 Jun 01; 115():159-167. PubMed ID: 28257810
    [Abstract] [Full Text] [Related]

  • 13. PE38KDEL-loaded anti-HER2 nanoparticles inhibit breast tumor progression with reduced toxicity and immunogenicity.
    Gao J, Kou G, Wang H, Chen H, Li B, Lu Y, Zhang D, Wang S, Hou S, Qian W, Dai J, Zhao J, Zhong Y, Guo Y.
    Breast Cancer Res Treat; 2009 May 01; 115(1):29-41. PubMed ID: 18481173
    [Abstract] [Full Text] [Related]

  • 14. Multiepitope HER2 targeting enhances photoimmunotherapy of HER2-overexpressing cancer cells with pyropheophorbide-a immunoconjugates.
    Savellano MD, Pogue BW, Hoopes PJ, Vitetta ES, Paulsen KD.
    Cancer Res; 2005 Jul 15; 65(14):6371-9. PubMed ID: 16024640
    [Abstract] [Full Text] [Related]

  • 15. In vivo targeting of OV-TL 3 immunoliposomes to ascitic ovarian carcinoma cells (OVCAR-3) in athymic nude mice.
    Nässander UK, Steerenberg PA, Poppe H, Storm G, Poels LG, De Jong WH, Crommelin DJ.
    Cancer Res; 1992 Feb 01; 52(3):646-53. PubMed ID: 1732053
    [Abstract] [Full Text] [Related]

  • 16. Tumor targeting of doxorubicin by anti-MT1-MMP antibody-modified PEG liposomes.
    Hatakeyama H, Akita H, Ishida E, Hashimoto K, Kobayashi H, Aoki T, Yasuda J, Obata K, Kikuchi H, Ishida T, Kiwada H, Harashima H.
    Int J Pharm; 2007 Sep 05; 342(1-2):194-200. PubMed ID: 17583453
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. HER2 specific tumor targeting with dendrimer conjugated anti-HER2 mAb.
    Shukla R, Thomas TP, Peters JL, Desai AM, Kukowska-Latallo J, Patri AK, Kotlyar A, Baker JR.
    Bioconjug Chem; 2006 Sep 05; 17(5):1109-15. PubMed ID: 16984117
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Sterically stabilized anti-G(M3), anti-Le(x) immunoliposomes: targeting to B16BL6, HRT-18 cancer cells.
    Nam SM, Kim HS, Ahn WS, Park YS.
    Oncol Res; 1999 Sep 05; 11(1):9-16. PubMed ID: 10451027
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 41.